Tibezonium iodide

This classification denotes an anti-infective agent with the molecular formula C28H32N3S2.I, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E9P274AJEW, chemically known as 2-(beta-(n-diethylamino)ethylthio)-4-(p-phenylthio)phenyl-3h-1,5-benzodiazepine methiodide but more generally known as tibezonium iodide, which bears US NIH Compound Identifier 41157. European Medicines Agency schedules Tibezonium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11021MIG. The term TIBEZONIUM IODIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules tibezonium iodide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule tibezonium iodide under HS 29339940 and SITC 51577. As of Q4 2014, TIBEZONIUM IODIDE remains US FDA's Preferred Term for this commodity. Tibezonium iodide bears US NLM identifiers UMLS ID C0772481 and NCI Concept Code C72650. SMILES: CC[N+](C)(CC)CCSC1=NC2CCCCC2N=C(C1)C3CCC(CC3)SC4CCCCC4.[I-].